SCHEMBL7120565

SCHEMBL7120565

O=C(Nc1ccc(Cl)cc1)c1c(O)c(Br)cc(Br)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 2/20 0.53
ALDH1A1 P00352 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
LMNA P02545 2/20 0.50
MAPK1 P28482 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MEN1 O00255 2/20 0.50
GAA P10253 1/20 0.50
EGFR P00533 1/20 0.50
ERBB2 P04626 1/20 0.50
CYP1A2 P05177 1/20 0.50
LCK P06239 1/20 0.50
CYP2C9 P11712 1/20 0.50
PTGS1 P23219 1/20 0.50
HTT P42858 1/20 0.50
MAPK14 Q16539 1/20 0.50
PRSS12 P56730 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25348233 0.83 TOP1 (0.56) P2RX1ALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL7122155 0.83 SNCA (0.54) P2RX1ALDH1A1KMT2AMAPTLMNA
SCHEMBL7116292 0.83 P2RX1 (0.56) P2RX1KMT2ASMN1; SMN2LMNAMAPK1
SCHEMBL11679716 0.80 KMT2A (0.80) P2RX1ALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL7120067 0.80 NPC1 (0.57) ALDH1A1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL7118151 0.78 RAB9A (0.54) ALDH1A1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL4355842 0.78 MEN1 (0.57) ALDH1A1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL14459536 0.77 F10 (0.68) P2RX1ALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL11790556 0.75 P2RX1 (0.55) P2RX1ALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL7120049 0.74 MAPT (0.60) ALDH1A1KMT2AMAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212074-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-13 US claimed
WO-2001082924-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-08 WO claimed
US-20030212074-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-13 US disclosed
WO-2001082924-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212074-A1 Phosphate transport inhibitors SLC34A2, SLC34A3, SLC34A1 P2RX1 370/4885ALDH1A1 3126/4885KMT2A 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.